Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hsu

Showing results (761-770 of 1,053) with videos related to

Pageof 106
Sort By:
Nature Communications|October 3, 2020
Functional role of Tet-mediated RNA hydroxymethylcytosine in mouse ES cells and during differentiationJie Lan, Nicholas Rajan, Martin Bizet, et al.
Molecular Cancer Therapeutics|May 3, 2015
AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AMLDaniel S Pereira, Claudia I Guevara, Liqing Jin, et al.
Human Molecular Genetics|November 28, 2017
De novo mutations in Caudal Type Homeo Box transcription Factor 2 (CDX2) in patients with persistent cloacaJacob S J Hsu, Manting So, Clara S M Tang, et al.
Journal of the National Cancer Institute|February 8, 2024
Association of differential censoring with survival and suboptimal control arms among oncology clinical trialsEric J Hsu, Timothy A Lin, Dor R Dabush, et al.
Journal of Therapeutic Ultrasound|September 29, 2015
Deep Bleeder Acoustic Coagulation (DBAC)-part II: in vivo testing of a research prototype systemK Michael Sekins, Stephen R Barnes, Liexiang Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell CarcinomaRaquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
Molecular Psychiatry|March 4, 2015
Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalitiesJ M Madison, F Zhou, A Nigam, et al.
Leukemia & Lymphoma|December 6, 2021
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphomaAhmad S Halwani, Carlos Panizo, Iris Isufi, et al.
Diabetes Technology & Therapeutics|March 10, 2021
Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control SystemMelissa J Schoelwer, Lauren G Kanapka, R Paul Wadwa, et al.
JAMA Oncology|October 12, 2023
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled TrialYongwoo David Seo, Hailing Lu, Graeme Black, et al.
Pageof 106

Showing results (761-770 of 1,053) with videos related to

Sort By:
Pageof 106
Nature Communications|October 3, 2020
Functional role of Tet-mediated RNA hydroxymethylcytosine in mouse ES cells and during differentiationJie Lan, Nicholas Rajan, Martin Bizet, et al.
Molecular Cancer Therapeutics|May 3, 2015
AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AMLDaniel S Pereira, Claudia I Guevara, Liqing Jin, et al.
Human Molecular Genetics|November 28, 2017
De novo mutations in Caudal Type Homeo Box transcription Factor 2 (CDX2) in patients with persistent cloacaJacob S J Hsu, Manting So, Clara S M Tang, et al.
Journal of the National Cancer Institute|February 8, 2024
Association of differential censoring with survival and suboptimal control arms among oncology clinical trialsEric J Hsu, Timothy A Lin, Dor R Dabush, et al.
Journal of Therapeutic Ultrasound|September 29, 2015
Deep Bleeder Acoustic Coagulation (DBAC)-part II: in vivo testing of a research prototype systemK Michael Sekins, Stephen R Barnes, Liexiang Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell CarcinomaRaquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
Molecular Psychiatry|March 4, 2015
Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalitiesJ M Madison, F Zhou, A Nigam, et al.
Leukemia & Lymphoma|December 6, 2021
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphomaAhmad S Halwani, Carlos Panizo, Iris Isufi, et al.
Diabetes Technology & Therapeutics|March 10, 2021
Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control SystemMelissa J Schoelwer, Lauren G Kanapka, R Paul Wadwa, et al.
JAMA Oncology|October 12, 2023
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled TrialYongwoo David Seo, Hailing Lu, Graeme Black, et al.
Pageof 106